Patients | Keeping pharma's end user at the centre

News

Australia starts probe into AI infiltration of Medicare

The infiltration of Australia's Medicare by an AI agent raises serious questions about patient privacy and the security of confidential pharma data.

News

Pharma leaders urge Europe to halt 'slow agony' of decline

Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

News

UK issues £45m funding call for research partnerships

The NIHR has revealed the first £45m in funding for projects that can bridge the translation gap in healthcare, focusing initially on community care.

News

UK needs 'clearer path for dementia diagnosis and treatment'

UK Prime Minister Andy Burnham, who lost his father to Alzheimer's last week, has been urged to implement a "cancer-style" reform of dementia care.

News

Judge blocks HHS' 340B rebate pilot at 11th hour

A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January.

Patients

pharmaphorum podcast Episode 237, Vinay Patel

Rethinking prescription drug affordability, with Vinay Patel

Vinay Patel, an innovative pharmacist, discuss the intricacies of drug pricing and accessibility in the US.

Patients

diabetes management tools and medications

Simplifying care to close the gap: Rethinking treatment burd...

Simplifying the complexity of medical treatments extends beyond convenience to improving equity.

News

Australia starts probe into AI infiltration of Medicare

The infiltration of Australia's Medicare by an AI agent raises serious questions about patient privacy and the security of confidential pharma data.

News

Pharma leaders urge Europe to halt 'slow agony' of decline

Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."

Press Releases

Digital

Partner Content

Newel Health awarded $2.5M Michael J. Fox research grant

Newel Health has been awarded a $2.5 million research grant from The Michael J. Fox Foundation.

Partner Content

Partner Content

The RARE Youth Revolution has begun

RARE Revolution Magazine proudly launches dedicated RARE youth online platform

Views & Analysis

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Patients

Why patient safety doesn't end at approval

Once a treatment becomes available to the public, protecting patient safety remains a priority throughout its time on the market.

Deep Dive

Patients

How to land a deal with big pharma

Patients

When drug prices collide: How US policy shifts are hitting p...

Patients

What’s powering the next wave of life sciences investment in...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Patients

Sponsored

Unlocking the Power of Storytelling in Medical Publications

In this era of accelerating information, it is more critical than ever to be clear and engaging in medical publications – and that increasingly involves the skill of scientific storytelling

Patients

Sponsored

Voices to Trials: Engaging Patients in Clinical Trial Design

To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho

Patients

Sponsored

Measuring the intangible – what is the true value of a “pati...

Podcasts

Patients

pharmaphorum podcast Episode 273, James Davis, PA Consulting

Delivering prevention at scale, PA Consulting’s James Davis

James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.

Patients

pharmaphorum podcast Episode 263, Rebecca Guntern - Sandoz

Biosimilars & patient access independent of geographies or s...

Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.

Patients

pharmaphorum podcast Episode 262, Lee-Ann Farrell, Johnson & Johnson

Towards a healthier world: Momentum in UK health system tran...

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Lee-Ann Farrell, Head of National Programmes at Johnson & Johnson.

Video

Patients

ASCO 2026: New hope in AL amyloidosis, with Dr Hans Lee

A phase 1/2 trial in AL amyloidosis saw 100% of patients obtaining at least a very good partial response with 90% obtaining a complete response.

Patients

ASCO 2026: Quality of life, not just quantity, with Dr Harol...

Dr Harold Keer, chief medical officer at Taiho Oncology, goes in-depth about why his company places such an emphasis on oral formulations.

Patients

Interview with Matt Wadyka at Reuters Pharma USA 2026

Making direct-to-patient work, with Matt Wadyka

Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.

White Papers

Oncology

Sponsored

Patient Centricity to Integration: Enhancing Cancer Outcomes

We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.

Debates & Insight

Sponsored

An integrated digital ecosystem to support patient outcomes,...

Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine has become a key focus for health authorities around the world

Debates & Insight

Sponsored

Patient centricity: How does Boehringer Ingelheim UK measure...

Patient centricity is a subject that is massively talked about but few can 'walk the talk'.

Event

Patients

Partner Content

Operationalize: Expanded Access Programs comes to the West C...

Improving Global Access to Life-Changing Therapeutics...

Patients

Reuters Pharma Barcelona 2023

The Reuters Pharma 2023 event is live in Barcelona and pharmaphorum is on site to provide readers with rolling coverage of the speakers and concepts as unfolds over the next few days.

Patients

Sponsored

Measuring the intangible – what is the true value of a “pati...

Views & Analysis

Words, inclusivity, and the struggle for health equality

Outdated or offensive terminology can reinforce barriers to clinical trial participation and accessible healthcare.

Views & Analysis

Sponsored

Understanding blockchain – a practical guide for life scienc...

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in distributed ledger technology (DLT) on the rise, then it would appear that momentum is b

Partner Content

Patients

Partner Content

Patient Recruitment for Rare Disease Trials Summit

Recruiting patients for rare disease trials is akin to finding a needle in a haystack, with challenges such as geographical dispersion, low awareness, and limited eligible patient pools.

Patients

Partner Content

How walking in a patient's shoes adds value to your patient ...

Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?

Patients

Partner Content

The PM Society – Giving Back

The PM Society is a not-for-profit organisation with 40 years of Giving Back.

News

Press Releases

Views & Analysis

Editor's Picks

Deep Dive

Webinars

Podcasts

Video

White Papers

Event

Debates & Insight

Partner Content

Editor's Picks